John is a translational researcher with a history of research studies on the basic neurophysiology of schizophrenia and autism. His work places special emphasis on the identification of endophenotypic markers in childhood neuropsychiatric diseases and in the linking of these biomarkers to the underlying genotype. Work in his lab has a consistent history of NIH, NSF, Foundation and Industry funding, and a strong record of research productivity (200+ publications).
John hails originally from Dublin, growing up in Ballygall and Castleknock. He studied English and History at UCD before leaving to continue his studies in New York. He is currently an Adjunct Professor in the Department of Psychology at Trinity College, where he maintains very strong collaborative links.
Before joining the faculty at Einstein in January of 2010 (his alma mater), John served for 6 years as the Director of the PhD Program in Cognitive Neuroscience at The City College of New York. He was recruited to Einstein in January of 2010 as the inaugural Director of Research for the Children’s Evaluation and Rehabilitation Center (CERC), with a mandate to develop and coordinate clinical pediatric research across the college. He currently serves as the Director of the Einstein Autism Research Center of Excellence and as the Associate Director of Einstein’s NIH-funded Rose F. Kennedy Intellectual and Developmental Disabilities Research Center.
His lab employs an integrated multi-methodological approach to issues in the cognitive neurosciences, using structural and functional neuroimaging, high-density electrophysiology, imaging genomics, eye tracking, psychophysics and virtual reality to understand the neural basis of basic sensory-perceptual and cognitive functions. The work is translational at its core in that it employs an equal mix of basic-science projects in healthy individuals with clinical studies in patient populations. The approach taken is to first develop novel assays of a given perceptual or cognitive function in healthy individuals, which are then deployed in clinical populations of interest. The core mission of the lab is to develop more effective treatments and interventions through establishing basic knowledge.